Read on Twitter
All those geopolitical experts who praised strategic masterstrokes in early April will they now take back their rhetoric? Of course not.
(Hydroxychloroquine, which Trump touted, is linked to higher rates of death in coronavirus patients, study says) https://www.washingtonpost.com/business/2020/04/21/anti-malarial-drug-trump-touted-is-linked-higher-rates-death-va-coronavirus-patients-study-says/">https://www.washingtonpost.com/business/...
(Hydroxychloroquine, which Trump touted, is linked to higher rates of death in coronavirus patients, study says) https://www.washingtonpost.com/business/2020/04/21/anti-malarial-drug-trump-touted-is-linked-higher-rates-death-va-coronavirus-patients-study-says/">https://www.washingtonpost.com/business/...
More than 27% of patients treated with hydroxychloroquine died, and 22% of those treated with the combination therapy died, compared with an 11.4% death rate.
(More and better trials are underway, but now there are massive strategic stockpiles of a drug that might not even work)
(More and better trials are underway, but now there are massive strategic stockpiles of a drug that might not even work)
Notably, the NIH said in their clinical guidelines yesterday that HCQ + A should not be administered to patients.
If you looked at the flawed early studies they had given HCQ to mild and moderate cases. Regardless, it’s unlikely to be the silver bullet that was claimed.
If you looked at the flawed early studies they had given HCQ to mild and moderate cases. Regardless, it’s unlikely to be the silver bullet that was claimed.
